VC-01 post-implant final

Stem cell good news: CIRM funds new cutting edge studies

July 23, 2016 admin 4

CIRM announced recently the funding of a number of exciting new studies. ViaCyte received additional funding to support its development of its hESC-based pancreatic progenitor cell product PEC-Direct clinic trials. This work is very promising. CIRM also funded additional diabetes-related research […]